×

Alexion to buy Synageva

4:20 PM ET Wed, 6 May 2015

Alexion's acquisition of Synageva is valued at $8.4 billion in cash and stock, reports CNBC's Meg Tirrell. Tom Lyndon, ETFtrends.com, discusses M&A trends in the biotech space.